SiRNA-Mediated Knockdown of ABCB1 Enhances the Efficacy of Doxorubicin and Vinorelbine in Breast Cancer Cells.

BACKGROUND: Breast cancer remains a leading cause of cancer-related deaths among women, primarily attributed to the formidable challenge of multidrug resistance, often driven by the overexpression of the ABCB1 gene. OBJECTIVE: This study aimed to assess the synergistic effects of siRNA, doxorubicin, and vinorelbine on ABCB1 gene expression and cell viability in doxorubicin-resistant MCF-7/ADR breast cancer cells, with siRNA targeting ABCB1 to reduce its expression and doxorubicin/ vinorelbine to eradicate cancer cells. METHODS: Our methodology involved culturing MCF-7 and MCF-7/ADR cells in standard cell culture conditions. The synthesized siRNA sequences transfected cells with siRNA at final concentrations of 10, 20, and 30 nM and assessed cell viability using the MTT assay was performed. Real-time PCR was employed to quantify ABCB1 mRNA expression levels. RESULTS: Results indicated that MCF-7/ADR cells exhibited substantial resistance to vinorelbine and doxorubicin compared to MCF-7 cells, displaying resistance at 12.50 µM and 25.00 µM for vinorelbine and 6.25 µM and 25.00 µM for doxorubicin. Remarkably, siRNA treatment effectively reversed drug resistance in MCF-7/ADR cells across all concentrations of vinorelbine and doxorubicin tested. When combined, siRNA, doxorubicin, and vinorelbine yielded a significantly greater reduction in cell viability compared to individual drug treatments, particularly at a 20 µM siRNA concentration. This combination therapy also significantly suppressed ABCB1 gene expression by a factor of 41.48 in MCF-7 cells relative to MCF-7/ADR cells. CONCLUSION: these findings suggest that combining siRNA, doxorubicin, and vinorelbine holds promise as a therapeutic strategy to overcome ABCB1-mediated multidrug resistance in breast cancer. Further investigations and clinical trials are warranted to evaluate its clinical efficacy rigorously.

The Persian version of the Cardiff Acne Disability Index. Reliability and validity study.

OBJECTIVE: The Cardiff Acne Disability Index (CADI) assesses the impact of acne on a patients life. The aim of the present study was to translate the CADI into Persian language and to validate the Persian version. METHODS: Using standard forward-backward translation, 2 bilinguals translated the CADI into Persian language. We back translated it into English and the final version was provided. We conducted this study from February through December 2004 on 100 patients with acne attending the Department of Dermatology, Jahrom Medical School, Jahrom, Iran who completed the Persian version of the CADI questionnaire. We carried out all statistical analyses using the Statistical Package for the Social Sciences version 11 for Windows. RESULTS: A total of 100 patients (15 men, 85 women) with acne participated in this study. The mean age of the patients was 20.76 +/- 2.94 years. Scores of the CADI ranged from 2-14 (7.57 +/- 2.58). Reliability analysis showed a satisfactory result (Cronbachs alpha coefficient = 0.79). Moreover, Pearsons correlation coefficient of 0.72 demonstrated the good internal consistency of the scale. CONCLUSION: The Persian version of the CADI questionnaire is a reliable, valid, and valuable tool for assessing the impact of acne on a patient's life.